iSTAR Medical Expands International Commercial Rollout of MINIject® with Successful First Implants Completed in Australia
Australia is the first territory outside of Europe for iSTAR Medical to have progressed its commercial roll out of MINIject®, following the successful expansion into countries including Germany, the UK, Switzerland, and most recently, Ireland.
- Australia is the first territory outside of Europe for iSTAR Medical to have progressed its commercial roll out of MINIject®, following the successful expansion into countries including Germany, the UK, Switzerland, and most recently, Ireland.
- With this expansion, glaucoma patients across Australia will now be able to benefit from MINIject®, the only commercially available supraciliary MIGS implant.
- MINIject® has demonstrated meaningful and sustained performance, combined with a favorable safety profile, and offers a treatment option for open-angle glaucoma.
- I would like to thank the clinicians involved for helping us achieve this significant milestone and look forward to reaching more patients throughout Australia and beyond.”